ADAM12 and breast carcinoma: To exclude that differences of LRP-1 shedding levels that we observed between the two breast cancer cell lines could be attributed to modulations of LRP-1, MT1-MMP and/or ADAM-12, its main sheddases (Selvais et al., 2011), we tested the effect of MβCD treatment on the expression of these three molecules.